 AZT activity cell lines implications combination chemotherapy immunotherapy sensitive quantitative focal immunoassay effects different therapeutic agents tissue culture cells human immunodeficiency virus HIV effects drugs cell lines agents azidothymidine AZT interferon-alpha IFN-alpha anti-HIV envelope antibody chain combination AZT effect early stages infection action cell lines effect AZT cells extended exposure drug removal IFN-alpha variable effects infected cells chronic infection Combinations therapeutic agents model treatment acute persistent stages infection effective combination HIV infection continual use AZT IFN-alpha tolerable doses Knowledge efficacy AZT cells effective design clinical protocols